Literature DB >> 3257399

Anti La(SSB) identifies a distinctive subgroup of systemic lupus erythematosus.

P J Maddison1, D A Isenberg, N J Goulding, J Leddy, R P Skinner.   

Abstract

The relevance of antibodies for La(SSB) as a marker of a distinctive systemic lupus erythematosus (SLE) subset was studied in 185 lupus patients. Anti La was detected in 39 (21%) and was accompanied invariably by anti Ro. Clinically, anti La-positive patients were distinguished by a later age of disease onset, and a low frequency of lupus nephritis. In common with other anti Ro-positive patients they showed a high frequency of keratoconjunctivitis sicca. Anti La identified patients with higher titres of anti Ro antibodies and was significantly associated with HLA-DR3. Serological markers such as these are useful for identifying more homogeneous populations of SLE patients for studies of aetiology and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257399     DOI: 10.1093/rheumatology/27.1.27

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  11 in total

1.  HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus.

Authors:  H A Stephens; N J McHugh; P J Maddison; D A Isenberg; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 2.  Autoantibodies to the RoRNP particles.

Authors:  M Reichlin
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

3.  HLA-DQw7 is a disease severity marker in patients with rheumatoid arthritis.

Authors:  H A Stephens; L I Sakkas; R W Vaughan; I Teitsson; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome.

Authors:  R A Asherson; H M Fei; H L Staub; M A Khamashta; G R Hughes; R I Fox
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

Review 5.  Anti-Ro(SSA) and anti-La(SSB) antibodies in autoimmune rheumatic diseases.

Authors:  P Youinou; Y Adler; S Muller; A Lamour; D Baron; R L Humbel
Journal:  Clin Rev Allergy       Date:  1994

Review 6.  Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus.

Authors:  A J Swaak; V Huysen; J C Nossent; R J Smeenk
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

7.  Analysis of antibodies to RNA in patients with systemic lupus erythematosus and other autoimmune rheumatic diseases.

Authors:  F Blanco; J Kalsi; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

8.  Antinuclear antibodies in routine analysis: the relevance of putative clinical associations.

Authors:  A J Swaak; V Huysen; R J Smeenk
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

9.  Autoantibody and idiotype profile of lung involvement in autoimmune rheumatic disease.

Authors:  L Turner-Stokes; P Haslam; M Jones; C Dudeney; S Le Page; D Isenberg
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

10.  Systemic lupus erythematosus: clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE.

Authors:  J Antolin; M J Amerigo; A Cantabrana; A Roces; P Jimenez
Journal:  Clin Rheumatol       Date:  1995-11       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.